ArticleProceedings of the National Academy of Sciences of the United States of America2019

Kinome profiling of non-Hodgkin lymphoma identifies Tyro3 as a therapeutic target in primary effusion lymphoma.

Jason P Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.